Evidence map›Paper›PMID 24744665›Full record

ArticleTurkish journal of haematology : official journal of Turkish Society of Haematology2012

Analysis of Chromosomal Aberrations and FLT3 gene Mutations in Childhood Acute Myelogenous Leukemia Patients.

Ender Coşkunpınar, Sema Anak, Leyla Ağaoğlu, Ayşegül Unüvar, Omer Devecioğlu, Gönül Aydoğan, Cetin Timur, Ahmet Faik Oner, Yıldız Yıldırmak, Tiraje Celkan and 3 more

Abstract read
In one paragraph

Article in Turkish journal of haematology : official journal of Turkish Society of Haematology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ender Coşkunpınarİstanbul University, Institute of Experimental Medical Research, Department of Genetics, İstanbul, Turkey.
Sema Anakİstanbul University, School of Medicine, Department of Pediatric Hematology-Oncology, İstanbul, Turkey.
Leyla Ağaoğluİstanbul University, School of Medicine, Department of Pediatric Hematology-Oncology, İstanbul, Turkey.
Ayşegül Unüvarİstanbul University, School of Medicine, Department of Pediatric Hematology-Oncology, İstanbul, Turkey.
Omer Devecioğluİstanbul University, School of Medicine, Department of Pediatric Hematology-Oncology, İstanbul, Turkey.
Gönül AydoğanBakırköy Maternity and Children's Hospital, İstanbul, Turkey.
Cetin TimurGöztepe Education and Research Hospital, Department of Pediatric Hematology, İstanbul, Turkey.
Ahmet Faik OnerYüzüncü Yıl University, School of Medicine, Department Of Pediatrics, Van, Turkey.
Yıldız YıldırmakŞişli Etfal Education and Research Hospital, Department of Pediatric Hematology, İstanbul, Turkey.
Tiraje Celkanİstanbul University, Cerrahpaşa School of Medicine, Department of Pediatric Hematology-Oncology, İstanbul, Turkey.
Inci Yıldızİstanbul University, Cerrahpaşa School of Medicine, Department of Pediatric Hematology-Oncology, İstanbul, Turkey.
Nazan SarperKocaeli University, School of Medicine, Department of Children's Health and Diseases, Kocaeli, Turkey.
Uğur Ozbekİstanbul University, Institute of Experimental Medical Research, Department of Genetics, İstanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo identify the well-known common translocations and FLT3 mutations in childhood acute myelogenousleukemia (AML) patients in Turkey. MATERIAL AND

methodsThe study included 50 newly diagnosed patients in which t(15;17), t(8;21), and inv(16)chromosomal translocations were identified using real-time PCR and FLT3 gene mutations were identified via direct PCR amplification PCR-RE analysis.

resultsIn all, t(15;17) chromosomal aberrations were observed in 4 patients (8.0%), t(8;21) chromosomal aberrationswere observed in 12 patients (24.0%), inv(16) chromosomal aberrations were observed in 3 patients (6.0%), and FLT3-ITD mutations were observed in 2 patients (4.0%); FLT3-D835 point mutation heterozygosity was observed in only 1patient (2.0%) patient.

conclusionDespite of the known literature, a patient with FLT3-ITD and FLT3-D835 double mutation shows a bettersurvival and this might be due to the complementation effect of the t(15;17) translocation. The reportedmutation ratein this article (4%) of FLT3 gene seems to be one of the first results for Turkish population.

Indexed as

Childhood AMLChromosomal translocationsD835 mutationsFLT3 gene mutationsITD

Identifiers

PMID24744665
PMCPMC3986746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.